Foley Hoag Represents H.I.G. BioHealth Partners and Accelmed Partners in $52M Series B Financing of Click Therapeutics

October 25, 2021

Foley Hoag LLP represented H.I.G. BioHealth Partners and Accelmed Partners as new investors and co-leads in the $52 million upsized Series B financing of digital therapeutics company Click Therapeutics, Inc. (“Click”). Health Catalyst Capital, Revelation Partners, a top biotechnology hedge fund, and existing investors Sanofi Ventures, K2 HealthVentures, Hikma Ventures and Ridgetop Health also participated in the round. Proceeds from the Series B financing will be used to accelerate the development and commercialization of Click’s internal prescription digital therapeutic pipeline and advance Click’s platform capabilities. In conjunction with the Series B financing, Click’s Board of Directors will expand to include Alex Zisson, Managing Director at H.I.G. BioHealth, and Dr. Uri Geiger, Founder and Managing Partner of Accelmed.

Click’s pipeline of innovative digital therapeutics spans multiple therapeutic areas, from psychiatry and chronic pain to cardiometabolic and autoimmune disorders. In addition to its internal pipeline programs, Click has entered into landmark collaboration agreements to develop and commercialize a prescription digital therapeutic for treatment of Major Depressive Disorder (MDD) and to develop and commercialize a prescription-based digital therapeutic to aid in the treatment of schizophrenia.

H.I.G. BioHealth Partners is the dedicated life-science investment affiliate of H.I.G. Capital. H.I.G. BioHealth Partners invests in a broad range of healthcare opportunities across sectors and stages, principally in companies developing therapeutic drugs, medical devices, and diagnostics for significant unmet medical needs.

Accelmed is a U.S.-based private equity firm focused on acquiring and investing in U.S. commercial stage, lower middle market HealthTech companies. Since 2009, Accelmed has deployed over $400 million into companies spanning medical devices, diagnostics, digital health and technology-enabled healthcare services. Accelmed seeks to accelerate value and scale innovation across the HealthTech field by bringing to bear the team’s industry experience, operational and financial expertise, and strong global relationships.

Foley Hoag attorneys Hemmie Chang, Patrick Connolly, John Harre, Erik Huestis, Ross Margulies, Jeffrey Quillen, Haider Andazola, Kimberly Cyrus and Mariah Figlietti represented H.I.G. BioHealth Partners and Accelmed Partners in the transaction. 

About Foley Hoag LLP

Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse backgrounds, perspectives and experiences of our lawyers and staff contribute to the exceptional service we deliver to clients ranging from startups to multinational companies to sovereign states. For more information, visit www.foleyhoag.com or follow @FoleyHoag on Twitter.